Leukemia inhibitory factor: Part of a large ingathering family

International Reviews of Immunology

Volumn 16, Issue 3-4, 1998, Pages 397-426

  Taupin, Jean Luc ^a   Pitard, Vincent ^a   Dechanet, Julie ^a   Miossec, Veronique ^a   Gualde, Norbert ^a   Moreau, Jean François ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cytokines; Gp130; Gp190; Immune response; Leukemia inhibitory factor; Oncostatin M

Indexed keywords

EID: 0031914865     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809043003     Document Type: Article

References (215)

1. Ishikawa, Y. Differentiation of a cell line of myeloid leukemia. J. Cell Physiol. 74, 223-34, 1969.
2. Metcalf, D., Hilton, D. J., and Nicola, N. A. Clonal variation in susceptibility to differentiation by different protein inducers in the myeloid leukemia cell line MI. Leukemia 2, 216-21, 1988.
3. Shabo, Y., Lotern, J., Rubinstein, M., Revel, M., Clark, S. C., Wolf, S. F., Kamen, R., and Sachs, L. The myeloid blood cell differentiation-inducing protein MGI-2A is IL-6. Blood 72, 2070-73, 1988.
4. Tomida, M., Yamamoto-Yamaguchi, Y., and Hozumi, M. Purification of a factor inducing differentiation of mouse myeloid leukemic MI cells from conditioned medium of mouse fibroblast L929 cells. J. Biol. Chem. 259, 10978-82, 1984.
5. Abe, T., Murakami, M., Sato, T., Kajiki, M., Olino, M., and Kodaira, R. Macrophage differentiation inducing factor from human monocytic cells is equivalent to murine LIF. J. Biol. Chem. 264, 8941-8945, 1989.
6. Lipton, J. H. and Sachs, L. Characterization of macrophage and granulocyte inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascities tumor. Biochem. Biophys Acta 673. 552-69, 1981.
7. Hilton, D. J., Nicola, N. A., and Metcalf, D. Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Anal. Biochem. 173, 359-67, 1988.
8. Simpson, R. J., Hilton, D. J., Nice, E. C., Rubira, M. R., Metcalf, D., Gearing, D. P., Gough, N. M., and Nicola, N. A. Structural characterization of a murine myeloid leukemia inhibitory factor. Eur. J. Biochem. 175, 541-47, 1988.
9. Gearing, D. P., Gough, N. M., King, J. A., Hilton, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A., and Metcalf, D. Molecular cloning and expression of a cDNA encoding a murine myeloid Leukemia Inhibitory Factor. EMBO J. 6, 3995-4002, 1987.
10. Gearing, D. P., King, J. A., and Gough, N. M. Complete sequence of murine leukemia inhibitory factor. Nucleic Acid Res. 16, 9857, 1988.
11. + human T-cell clones. Proc. Natl. Acad. Sci. USA 82, 7020-24, 1985.
12. Moreau, J. F., Bonneville, M., Peyrat, M. A., Jacques, Y., and Soulillou, J. P. Capacity of alloreactive human T cell clones to produce factor(s) inducing proliferation of the IL3-dependent DA-1 murine cell line. Ann Inst. Pasteur Immunol. 137C, 25-37, 1986.
13. Moreau, J. F., Bonneville, M., Godard, A., Gascan, H., Gruart, V., Moore, M. A., and Soulillou, J. P. Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. J. Immunol. 138, 3844-49, 1987.
14. Godard, A., Gascan, H., Naulet, J., Peyrat, M. A., Jacques, Y., Soulillou, J. P., and Moreau, J. F. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71, 1618-23, 1988.
15. Moreau, J. F., Donaldson, D. D., Bennett, F., Witek-Giannotti, J. A., Clark, S. C., and Wong, G. G. Leukemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336, 690-692, 1988.
16. Smith, A. G., Heath, J. K., Donaldson, D. D., Wong, G. G., Moreau, J. F., Stahl, M., and Rogers, D. Inhibition of pluripotential embryonic stem cells differentiation by purified polypeptides. Nature 336, 688-690, 1988.
17. Gough, N. M., Gearing, D. P., King, J. A., Willson, T. A., Hilton, D. J., Nicola, N. A., and Metcalf, D. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid Leukemia Inhibitory Factor. Proc. Natl. Acad. Sci. USA 88, 2623-27, 1988.
18. Koopman, P. and Cotton, R. G.H. A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation. Characterization and partial purification. Exp. Cell Res. 154, 233-42, 1984.
19. Williams, R. L., Hilton, D. J., Pease, S., Willson, T. A., Stewart, C. L., Gearing, D. P , Wagner, E. F., Metcalf, D., Nicola, N. A., and Gough, N. M. Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684-87, 1988.
20. Heath, J. K. Can there be life without LIF? Nature 359, 17, 1992.
21. Yamamori, T., Fukada, K., Aebersold, R., Korsching, S., Fann, M. J., and Patterson, P. H. The Cholinergic Neuronal Differentiation Factor from heart cells is identical to Leukemia Inhibitory Factor. Science 246, 1412-16, 1989.
22. Schotzinger, R., Yin, X., and Landis, S. Target determination of neurotransmitter phenotype in sympathetic neurons. J. Neurobiol. 25, 620-39, 1994.
23. Abe, E., Tanaka, H., Ishimi, Y., Miyaura, C., Hayashi, T., Nagasawa, H., Tomida, M., Yamaguchi, Y., Hozumi, M., and Suda, T. Differentiation Inducing Factor purified from conditioned medium of mitogen-treated spleen cultures stimulates bone resorption. Proc. Natl. Acad. Sci. USA 83, 5958-62, 1986.
24. Cornish, J., Callon, K., King, A., Edgar, S., and Reid, I. R. The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 132, 1359-1366, 1993.
25. Mori, M., Yamaguchi, K., and Abe, K. Purification of a lipoprotein lipase inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem. Biophys. Res. Commun. 160, 1085-92, 1989.
26. Marshall, M. K., Doerrler, W., Feingold, K. R., and Grunfeld, C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 135, 141-7, 1994.
27. Austin, L., Bower, J., Kurek, J., and Vakakis, N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J. Neurol. Sci. 112, 185-91, 1992.
28. Bower, J., Vakakis, N., Nicola, N. A., and Austin, L. Specific binding of leukemia inhibitory factor to murine myoblasts in culture. J. cell. Physiol. 164, 93-8, 1995.
29. Maley, M. A., Davies, M. J., and Grounds, M. D. Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp. cell. Res. 219, 169-79, 1995.
30. Kushima, Y. and Hatanaka, H. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci. Lett. 143, 110-4, 1992.
31. Matsui, Y., Toksoz, D., Nishikawa, S., Nishikawa, S. I., Williams, D., Zsebo, K., and Hogan, B. L. M. Effect of Steel Factor and leukemia inhibitory factor on murine primordial germ cells in culture. Nature 353, 750-752, 1991.
32. De Felici, M. and Dolci, S. Leukemia Inhibitory Factor sustains the survival of mouse primordial germ cells cultured on TM4 feeder layers. Dev. Biol. 147, 281-84, 1991.
33. Matsui, Y., Zsebo, K., and Hogan, B. L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70, 841-7, 1992.
34. de Miguel, M. P., de Boer-Brouwer, M., Paniagua, R., van den Hurk, R., de Rooooij, D., and van Dissel-Emiliani, F. M. F. LIF and CNTF promote the survival of Sertoli cells and gonocytes in a culture system. Endocrinology 137, 1885-93, 1996.
35. Estrov, Z., Talpaz, M., Wetzler, M., and Kurzrock, R. The modulatory hematopoietic activities of leukemia inhibitory factor. Leuk. Lymphoma. 8, 1-7, 1992.
36. Akita, S., Webster, J., Ren, S. G., Takino, H., Said, J., Zand, O., and Melmed, S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest. 95, 1288-98, 1995.
37. Benigni, F., Fantuzzi, G., Sacco, S., Sironi, M., Pozzi, P., Dinarello, C A., Sipe, J. D., Poli, V., Cappelletti, M., Paonessa, G., Pennica, D., Panayotatos, N., and Ghezzi, P. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 87, 1851-4, 1996.
38. Ferrara, N., Winer, J., and Henzel, W. J. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 89, 698-702, 1992.
39. Gillett, N. A., Lowe, D., Lu, L., Chan, C., and Ferrara, N. Leukemia inhibitory factor expression in human carotid plaques: possible mechanism for inhibition of large vessel endothelial regrowth. Growth Factors 9, 301-5, 1993.
40. Grosset, C., Jazwiec, B., Taupin, J. L., Liu, H., Richard, S., Mahon, F. X., Reiffers, J., Moreau, J. F., and Ripoche, J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 86, 3763-70, 1995.
41. Baumann, H. and Wong, G. G. Hepalocyte Stimulating Factor III shares structural and functional identity with Leukemia Inhibitory Factor. J. Immunol. 143, 1163-1167, 1989.
42. Mirshahi, S. S., Vasse, M., Soria, C., Moreau, J. F., Taupin, J. L., Mirshahi, M., Pujade-Lauraine, E., Bernadou, A., and Soria, J. Incubation of monocytes with adriamycin increases secretion of hepatocyte stimulating factor for fibrinogen biosynthesis. Blood Coagulation & Fibrinolysis 4, 149-152, 1993.
43. Richards, C. D., Brown, T. J., Shoyab, M., Baumann, H., and Gauldie, J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148, 1731-6, 1992
44. Mayer, P., Geissler, K., Ward, M., and Metcalf, D. Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 81, 3226-33, 1993.
45. Pierzchalski, P., Rokita, H., Koj, A., Fries, E., and Akerstrom, B. Synthesis of alpha 1-microglobulin in cultured rat hepatocytes is stimulated by interleukin-6, leukemia inhibitory factor, dexamethasone and retinoic acid. FEBS Lett. 298, 165-8, 1992.
46. Le, P. T., Lazorick, S., Whichard, L. P., Yang, Y. C., Clark, C. S., Haynes, B. F., and Singer, K. H. Human thymic epithelial cells produce IL-6, Granulocyte-Monocyte-CSF, and Leukemia Inhibitory Factor. J. Immunol. 145, 3310-15, 1990.
47. Sakata, T., Iwagami, S., Tsuruta, Y., Yamaguchi, M., Michishita, M., Nagata, K., Takai, Y., Ogata, M. Teraoka, H., and Fujiwara, H. Constitutive expression of leukemia inhibitory factor (LIF) mRNA and production of LIF by a cloned murine thymic stromal cell line. Thymus 19, 89-95, 1992.
48. Escary, J. L., Perreau, J., Dumenil, D., Ezine, S., and Brulet, P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363, 361-4, 1993.
49. Shen, M. M., Skoda, R. C., Cardiff, R. D., Campos-Torres, J., Leder, P., and Ornitz, D. M. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 13, 1375-85, 1994.
50. Gascan, H., Godard, A., Ferenz, C., Naulet, J., Praloran, V., Peyrat, M. A, Hewick, R., Jacques, Y., Moreau, J. F., and Soulillou, J. P. Characterization and amino-terminal aminoacid sequence of natural human interleukin for DA cells/ leukemia inhibitory factor. J. Biol. Chem. 264, 21509-15, 1989.
51. Gearing, D. P., Nicola, N. A., Metcalf, D., Foote, S., Willson, T. A., Gough, N. M., and Williams, R. L. Production of leukemia inhibitory factor in E. coli by a novel procedure and its use in maintaining embryonic stem cells in culture. Biotechnology 7, 1157-1161, 1989.
52. Shaw, G., and Kamen, R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-66, 1986.
53. Lowe, D. G., Nunes, W., Bombara, M., Mc Cabe, S., Ranges, G. E., Henzel, W., Tomida, M., Yamamoto-Yamaguchi, Y., Hozumi, M., and Goeddel, D. V. Genomic cloning and heterologous expression of human differentiation-stimulating factor. DNA 8, 351-59, 1989.
54. Hallet, M. M., Peyrat, M. A., Soulillou, J. P., and Moreau, J. F. Simultaneous transcription of eleven cytokines in human alloreactive T lymphocyte clones after stimulation by phorbol ester and A23187. Eur. Cytokine Netw. 3, 477-83, 1992.
55. Hamilton, J. A., Waring, P. M., and Filonzi, E. L Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J. Immunol. 150, 1496-502, 1993.
56. Campbell, I. K., Waring, P., Novak, U., and Hamilton, J. A. Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum. 36, 790-4, 1993.
57. Lorenzo, J. A., Jastrzebski, S. L., Kalinowski, J. F., Downie, E., and Korn, J. H. Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures. Clin. Immunol. Immunopathol. 70, 260-5, 1994.
58. Dechanet, J., Taupin, J. L., Chomarat, P., Rissoan, M. C., Moreau, J. F., Banchereau, J., and Miossec, P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 24, 3222-8, 1994.
59. Ulich, T. R., del Castillo, J., Shin, S. S., Yin, S., Duryea, D., Tarpley, J., and Samal, B. Hematologic effects of stem cell factor (SCF) and leukemia inhibitory factor (LIF) in vivo: LIF-induced thrombocytosis in SCF-primed mice. Eur. J. Haematol. 54, 217-25, 1995.
60. Wetzler, M., Estrov, Z., Talpaz, M., Kim, K. J., Alphonso, M., Srinivasan, R., and Kurzrock, R. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha. Cancer Res. 54, 1837-42, 1994.
61. Lecron, J. C., Roblot, P., Chevalier, S., Morel, F., Alderman, E., Gombert, J., and Gascan, H. High circulating LIF in patients with giant cell arteritis: independent regulation of LIF and IL6 under corticosteroid therapy. Clin. Exp. Immunol. 92, 23-26, 1993.
62. Bentouimou, N., Moreau, J. F, Peyrat, M. A., Soulillou, J. P., and Hallet, M. M. The effects of cyclosporine on HILDA/LIF gene expression in human T cells. Transplantation 55, 163-67, 1993.
63. Imamura, M., Zhu, X., Hashino, S., Han, C. W., Tanaka, J., Kobayashi, H., Imai, K., Kasai, M., Sakurada, K., and Miyazaki, T. Effects of 15-deoxyspergualin on proliferative responses and cytokine gene expression in vitro. Immunobiology 192, 27-39, 1994.
64. Wetzler, M., Kurzrock, R., Estrov, Z., Estey, E., and Talpaz, M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk. Res. 19, 23-34, 1995.
65. Sutherland, G. R., Baker, E., Hyland, V. J., Callen, D F., Stahl, J., and Gough, N. M. The gene for leukemia inhibitory factor (LIF) maps to 22q12. Leukemia. 3, 9-13, 1989.
66. Pergolizzi, R. G., and Erster, S. H. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus. Mol. Chem. Neuropathol. 21, 189-217, 1994.
67. Kola, I., Davey, A., and Gough, N. A. Localization of the murine leukemia inhibitory factor gene near the centromere on chromosome 11. Growth Factors 2, 235-40, 1990.
68. Bottorff, D. and Stone, J. C. The murine leukemia inhibition factor gene (LIF) is located on proximal chromosome 11, not chromosome 13. Mamm. Genome 3, 681-4, 1992.
69. Budarf, M., Emanuel, B. S., Mohandas, T., Goeddel, D. V., and Lowe, D. G. Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q Cytogenet. Cell Genet. 52, 19-22, 1989.
70. Stahl, J., Gearing, D. P., Willson, T. A., Brown, M. A., King, J. A., and Gough, N. M. Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. J. Biol. Chem. 265, 8833-41, 1990.
71. Stahl, J. and Gough, N. M. Delineation of positive and negative control elements within the promoter region of the murine leukemia inhibitory factor (LIF) gene. Cytokine 5, 386-93, 1993.
72. Bruce, A. G., Linsley, P. S., and Rose, T. M. Oncostatin M. Progress in Growth Factor Research 4, 157-70, 1992.
73. Giovannini, M., Selleri, L., Hermanson, G. G., and Evans, G. A. Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint. Cytogenet. Cell Genet, 62, 32-4, 1993.
74. Jeffery, E., Price, V., and Gearing, D. P. Close proximity of the genes for leukemia inhibitory factor and oncostatin M. Cytokine 5, 107-11, 1993.
75. Giovannini, M., Djabali, M., McElligott, D., Selleri, L., and Evans, G. A. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22. Cytogenet. Cell Genet. 64, 240-4, 1993.
76. Rose, T. M., Lagrou, M. J., Fransson, I., Werelius, B., Delattre, O., Thomas, G., de Jong, P. J., Todaro, G. J., and Dumanski, J. P. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics 17, 136-40, 1993.
77. Gearing, D. P. and Bruce, A. G. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biologist 4, 61-5, 1992.
78. Liu, J., Modrell, B., Aruffo, A., Scharnowske, S., and Shoyab, M. Interactions between OSM and the IL6 signal transducer, gp130. Cytokine 6, 272-78, 1994.
79. Rathjen, P. D., Toth, S., Willis, A., Heath, J. K., and Smith, A. G. Differentiation inhibiting activity/leukemia inhibitory factor (DIA/LIF) is produced in matrix-associated and diffusible forms generated by alternate promoter usage. Cell 62, 1105-1114, 1990.
80. Willson, T. A., Metcalf, D., and Gough, N. M. Cross-species comparison of the sequence of the leukemia inhibitory factor gene and its protein. Eur. J. Biochem. 204, 21-30, 1992.
81. Robertson, M., Chambers, I., Rathjen, P., Nichols, J., and Smith, A. Expression of alternative forms of differentiation inhibiting activity (DIA/LIF) during murine embryogenesis and in neonatal and adult tissues. Dev. Genet. 14, 165-73, 1993.
82. Conquet, F., Peyrieras, N., Tiret, L., and Brulet, P. Inhibited gastrulation in mouse embryos overexpressing the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 89, 8195-19, 1992.
83. Shen, M. M. and Leder, P. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc. Natl. Acad. Sci. USA 89, 8240-4, 1992.
84. Gupta, P., McCarthy, J. B., and Verfaillie, C. M. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 87, 3229-36, 1996.
85. Tomida, M., Yamamoto-Yamaguchi, Y., and Hozumi, M. Three different cDNAs encoding mouse D-factor/LIF receptor. J. Biochem. 115, 557-62, 1994.
86. Tomida, M. Analysis of recombinant soluble mouse D-factor/LIF receptor. J. Biochem. 117, 1228-31, 1995.
87. Owczarek, C. M., Layton, M. J., Robb, L. G., Nicola, N. A., and Begley, C. G. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice. J. Biol. Chem. 271, 5495-504, 1996.
88. Mereau, A., Grey, L., Piquet-Pellorce, C., and Heath, J. K. Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix. J. Cell. Biol. 122, 713-9, 1993.
89. Layton, M. J., Cross, B. A., Metcalf, D., Ward, L. D., Simpson, R. J., and Nicola, N. A. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor, Proc. Natl. Acad. Sci. USA 89, 8616-20, 1992.
90. Nicola, N. A., Cross, B., and Simpson, R. J. The disulfide bond arrangement of leukemia inhibitory factor: homology to oncostatin M and structural implications. Biochem. Biophys. Res. Comm. 190, 20-6, 1993.
91. Betzel, C., Visanji, M., Dauter, Z., Fourme, R., Weber, W., Marnitz, U., Boone, T., Pope, J., Miller, J., and Hawkins, N. Crystallization and preliminary X-ray analysis of leukemia inhibitory factor. FEBS Lett. 336, 236-8, 1993.
92. Smith, D. K., Treutlein, H. R., Maurer, T., Owczarek, C. M., Layton, M. J., Nicola, N. A., and Norton, R. S. Homology modelling and 1H NMR studies of human leukaemia inhibitory factor. FEBS Lett. 350, 275-80, 1994.
93. Robinson, R. C., Grey, L. M., Staunton, D., Vankelecom, H., Vernallis, A. B., Moreau, J. F., Stuart, D. I., Heath, J. K., and Jones, E. Y. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77, 1101-16, 1994.
94. Maurer, T., Smith, D. K., Owczarek, C. M., Layton, M. J., Zhang, J. G., Nicola, N. A., and Norton, R. S. NMR studies of a murine-human chimera of LIF. Comparison with human LIF. Growth Factors 11, 271-6, 1994.
95. de Vos, A. M., Ultsch, M., and Kossiakoff, A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312, 1992.
96. Bazan, J. F. Neuropoietic cytokines in the hematopoietic fold. Neuron 7, 197-208, 1991.
97. Hill, C. P., Osslund, T. D., and Eisenberg, D. The structure of granulocyte colony stimulating factor and its relationship to other growth factors. Proc. Natl. Acad. Sci. USA 90, 5167-5171, 1993.
98. Godard, A., Heymann, D., Raher, S., Anegon, I., Peyrat, M. A., Le Mauff, B., Mouray, E., Gregoire, M., Virdee, K., Soulillou, J. P., Moreau, J. F., and Jacques, Y. High and low affinity receptors for human interleukin for DA cells/ leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 267, 3214-22, 1992.
99. Hartner, A., Goppelt-Strube, M., Hocke, G., Fey, G., and Sterzel, R. B. Renal mesangial cells have the capacity to synthetize and react to LIF. Ann. NY Acad. Sci. 762, 424-5, 1995.
100. Hilton, D. J., Nicola, N. A., and Metcalf, D. Distribution and comparison of the receptors for LIF on murine hemopoietic and hepatic Cells. J. Cell Physiol. 146, 207-215, 1991.
101. Hilton, D. J. and Nicola, N. A. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J. Biol. Chem. 267, 10238-47, 1992.
102. Sasaki, H., HIrabayashi, Y., Ishibashi, T., Inoue, T., Matsuda, M., Kai, S., Ikuta, K., Yokoyama, K., Yokota, T., and Maruyama, Y. Effects of Epo, IL3, IL6 and LIF on a murine megakaryoblastic cell line: growth enhancement and expression of receptor mRNAs. Leuk. Res. 19, 95-102, 1995.
103. Van Damme, J., Uyttenhove, C., Houssiau, F., Put, W., Proost, P., and Van Snick, J. Human growth factor for murine interleukin IL9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA. Eur. J. Immunol. 22, 2801-8, 1992.
104. Zhang, X. G., Gu, J. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R., and Klein, B. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 179, 1337-42, 1994.
105. Nishimoto, N., Ogata, A., Shima, Y., Tani, Y., Ogawa, H., Nakagawa, M., Sugiyama, H., Yoshizaki, K., and Kishimoto, T. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J. Exp. Med. 179, 1343-7, 1994.
106. Mattel, S., Colombo, M. P., Melani, C., Silvani, A., Parmiani, G., and Herlyn, M. Expression of cytokine/growth Factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 56, 853-7, 1994.
107. Gu, Z. J., Costes, V., Lu, Z. Y., Zhang, X. G., Pitard, V., Moreau, J. F., Bataille, R., Wijdenes, J., Rossi, J. F., and Klein, B. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 88, 3972-3986, 1996.
108. Bellido, T., Stahl, N., Farruggella, T. J., Borba, V., Yancopoulos, G. D., and Manolagas, S. C. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J. Clin. Invest. 97, 431-7, 1996.
109. Kamohara, H., Sakamoto, K., Ishiko, T., Mita, S., Masuda, Y., Abe, T., and Ogawa, M Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF). Res. Commun. Mol. Pathol. Pharmacol. 85, 131-40, 1994
110. Takanashi, M., Motoji, T., Masuda, M., Oshimi, K., and Mizoguchi, H. The effects of leukemia inhibitory factor and interleukin 6 on the growth of acute myeloid leukemia cells. Leuk. Res. 17, 217-22, 1993.
111. Portier, M., Zhang, X. G., Ursule, E., Lees, D., Jourdan, M., Bataille, R., and Klein, B. Cytokine gene expression in human multiple myeloma. Br. J. Haematol. 85, 514-20, 1993.
112. Estrov, Z., Samal, B., Lapushin, R., Kellokumpu-Lehtinen, P., Sahin, A. A., Kurzrock, R., Talpaz, M., and Aggarwal, B. B. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon. Cytokme Res. 15, 905-13, 1995.
113. Kellokumpu-Lehtinen, P., Talpaz, M., Harris, D., Van, Q., Kurzrock, R., and Estrov, Z. Leukemia inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int. J. Cancer 66, 515-9, 1996.
114. Gearing, D. P., Thut, C. J., VandenBos, T., Gimpel, S. D., Delaney, P. B., King, J., Price, V., Cosman, D., and Beckmann, M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10, 2839-48, 1991.
115. Gough, N. M. Molecular genetics of LIF and its receptor. Growth Factors 7, 175-9, 1992.
116. Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S. D., Thut, C. J., McGourty, J., Brasher, K. K., King, J. A., Gillis, S., Mosley, B., Ziegler, S. F., and Cosman, D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255, 1434-7, 1992.
117. Nicola, N. A., Robb, L., Metcalf, D., Cary, D., Drinkwater, C. C., and Begley, G. Functional inactivation in mice of the gene for the IL3-specific receptor beta-chain: implications for IL3 function and the mechanism of the receptor transmodulation in hematopoietic cells. Blood 87, 2665-74, 1996.
118. Noguchi, M., Yi, H., Rosenblatt, H. M., Filipovich, A. H., Adelstein, S., Modi, W. S., McBride, O. W., and Leonard, W. J. IL2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-57, 1993.
119. Bazan, J. F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, IL6 and erythropoietin receptors, and the p75 IL2 receptor beta-chain. Biochem. Biophys. Res. Commun. 164, 788-796, 1989.
120. Bazan, J. F. Haematopoietic receptors and helical cytokines. Immunol. Today 11, 350-354, 1990.
121. Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J, Yasukawa, K., Kishimoto, T., Anderson, D. J., Stahl, N., and Yancopoulos, G. D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69, 1121-32, 1992.
122. Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G. D., and Kishimoto, T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 89, 10998-1001, 1992.
123. Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., and Kishimoto, T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260, 1808-10, 1993.
124. Stahl, N., Davis, S., Wong, V., Taga, T., Kishimoto, T., Ip, N. Y., and Yancopoulos, G. D. Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component. J. Biol. Chem. 268, 7628-31, 1993.
125. Davis, S., Aldrich, T. H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip, N. Y., and Yancopoulos, G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 260, 1805-8, 1993
126. Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrim, S., Ihle, J. N., and Yancopoulos, G. D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263, 92-5, 1994.
127. Thoma, B., Bird, T. A., Friend, D. J., Gearing, D. P., and Dower, S. K. Oncostatin M and Leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 269, 6215-22, 1994.
128. Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., Kishimoto, T., and Taga, T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 91, 2285-9, 1994.
129. Feldman, M., Petricoin, E. F., David, M., Larner, A. C., and Finbloom, D. S. Cytokines that associate witn the signal transducer gp130 activate the interferon-induced transcription factor p91 by tyrosine phosphorylation. J. Biol. Chem. 269, 10747-52, 1994.
130. Ernst, M., Gearing, D. P., and Dunn, A. R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 13, 1574-84, 1994.
131. Hilton, D. J., Hilton, A. A., Raicevic, A., Rakar, S., Harrison-Smith, M., Gough, N. M., Begley, C. G, Metcalf, D., Nicola, N. A., and Willson, T. A. Cloning of a marine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13, 4765-75, 1994.
132. Kalberg, C., Yung, S. Y., and Kessler, J. A. The cholinergic stimulating effects of ciliary neurotrophic factor and leukemia inhibitory factor are mediated by protein kinase C. J. Neurochem. 60, 145-52, 1993.
133. Yin, T. and Yang, Y. C. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem. 269, 3731-8, 1994.
134. Schiemann, W. P. and Nathanson, N. M. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways. J. Biol. Chem. 269, 6376-82, 1994.
135. Akira, S., Nishio, Y., Inoue, M., Wang, X. J., Wei, S., Matsusaka, T., K, Y., Sudo, T., Naruto, M., and Kishimoto, T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71, 1994.
136. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. Ciliary neurotrophic factor/ leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 269, 11648-55, 1994.
137. Schiemann, W. P., Graves, L. M., Baumann, H., Morella, K. K., Gearing, D. P., Nielsen, M. D., Krebs, E. G., and Nathanson, N. M. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc. Natl. Acad. Sci. USA 92, 5361-5, 1995.
138. Matsuda, T., Fukada, T., Takahashi-Tezuka, M., Okuyama, Y., Fujitani, Y., Hanazono, Y., Hirai, H., and Hirano, T. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 270, 11037-9, 1995.
139. Chauhan, D., Kharbanda, S. M., Ogata, A., Urashima, M., Frank, D., Malik, N., Kufe, D. W., and Anderson, K. C. Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells. J. Exp. Med. 182, 1801-6, 1995.
140. Livnah, O., Stura, E. A., Johnson, D. L., Middleton, S. A., Mulcahy, L. S., Wrighton, N. C., Dower, W. J., Jolliffe, L. K., and Wilson, I. A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å. Science 273, 464-71, 1996.
141. Cosman, D. The hematopoietin receptor superfamily. Cytokine 5, 95-106, 1993.
142. Miyasaki, T., Maruyama, M., Yamada, G., Hatakeyama, M., and Taniguchi, T. The integrity of the conserved "WS motif" common to IL2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J. 10, 3191-97, 1991.
143. Hilton, D. J., Watowich, S. S., Katz, L., and Lodish, H. F. Saturation mutagenesis of the WSXWS motif of the erthropoietin receptor. J. Biol. Chem. 271, 4699-4708, 1996.
144. Hiraoka, O., Anaguchi, H., Asakura, A., and Ota, Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J. Biol. Chem. 270, 25928-34, 1996.
145. Tomida, M., Yamamoto-Yamaguchi, Y., and Hozumi, M. Pregnancy associated increase in mRNA for soluble D-factor/LIF receptor in mouse liver. FEBS Lett. 334, 193-7, 1993.
146. Yamaguchi-Yamamoto, Y., Tomida, M., and Hozumi, M. Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Leuk. Res. 17, 515-22, 1993.
147. Baumann, H., Ziegler, S. F., Mosley, B., Morella, K. K., Pajovic, S., and Gearing, D. P. Reconstitution of the response to LIF, OSM, and CNTF in hepatoma cells. J. Biol. Chem. 268, 8414-17, 1992.
148. Heymann, D., Godard, A., Raher, S., Bentouimou, S., Blanchard, F., Cherel, M., Hallet, M. M., and Jacques, Y. Leukemia Inhibitory Factor and Oncostatin M high affinity binding require additional receptor subunits besides gp130 and gp190. Cytokine 8, 197-205, 1996.
149. Mosley, B., Delmus, C., Friend, D., Thoma, B., and Cosman, D. The OSM receptor: cloning of a novel subunit related to the LIF receptor (Abstract A92). Cytokine 6, 554, 1994.
150. Sporeno, E., Paonessa, G., Salvati, A. L., Graziani, R., Delmastro, P., Ciliberto, G., and Toniatti, C. OSM binds directly to gp130 and behaves as IL6 antagonist on a cell line expressing gp130 but lacking functional OSM receptors. J. Biol. Chem. 269, 10991-95, 1994.
151. Layton, M. J., Lock, P., Metcalf, D., and Nicola, N. A. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. J. Biol. Chem. 269, 17048-55, 1994.
152. Owczarek, C. M., Layton, M. J., Metcalf, D., Lock, P., Willson, T. A., Gough, N. M., and Nicola, N. A. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant. EMBO J. 12, 3487-95, 1993.
153. Layton, M. J., Owczarek, C. M., Metcalf, D., Clark, R. L., Smith, D. K., Treutlein, H. R., and Nicola, N. A. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. J. Biol. Chem. 269, 29891-6, 1994.
154. Cunningham, B. C. and Wells, J. A. Comparison of a structural and functional epitope. Mol. Biol. 234, 5554-63, 1993.
155. Ciapponi, L., Graziani, R., Paonessa, G, Lahm, A., Ciliberto, G., and Savino, R. Definition of a composite binding site for gp130 in human interleukin-6. J. Biol. Chem. 270, 31249-54, 1995.
156. Metcalf, D. and Gearing, D. P. Fatal syndrome in mice engrafted with cells producing high levels of LIF. Proc. Natl. Acad. Sci. USA 86, 5948-52, 1989.
157. Metcalf, D. and Gearing, D. P A myelosclerotic syndrome in mice engrafted with cells producing high levels of LIF. Leukemia 3, 847-52, 1990.
158. Metcalf, D., Nicola, N. A., and Gearing, D. P. Effects of injected LIF on hematopoietic and other tissues in mice. Blood 76, 50-6, 1990.
159. Waring, P., Wycherley, K., Cary, D., Nicola, N., and Metcalf, D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J. Clin. Invest. 90, 2031-7, 1992.
160. Brown, M. A., Metcalf, D., and Gough, N. M. Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 6, 300-9, 1994.
161. Feingold, K. R., Marshall, M., Gulli R., Moser, A. H., and Grunfeld, C. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler. Thromb. 14, 1866-72, 1994.
162. Villers, D., Dao, T., Nguyen, J. M., Bironneau, E., Godard, A., Moreau, M., De Groote, D., Nicolas, F., Soulillou, J. P., and Anegon, I. Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J. Infect. Dis. 171, 232-6, 1995.
163. Waring, P. M., Waring, L. J., Billington, T., and Metcalf, D. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc. Natl. Acad. Sci. USA 92, 1337-41, 1995.
164. Waring, P. M., Waring, L. J., and Metcalf, D. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J. Infect. Dis. 170, 1224-8, 1994.
165. Alexander, H. R., Wong, G. G., Doherty, G. M., Venzon, D. J., Fraker, D. L., and Norton, J. A. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J. Exp. Med. 175, 1139-42, 1992.
166. Jansen, P. M., de Jong, I. W., Hart, M., Jin Kim, K., Aarden, L. A., Hinshaw, L. B., Taylor, F. B., and Hack, E. Release of LIF in primate sepsis. Analysis of the role of TNF alpha. J. Immunol. 156, 4401-07, 1996.
167. Waring, P. M., Romero, R., Laham, N., Gomez, R., and Rice, G. E. Leukemia inhibitory factor: association with intraamniotic infection. Am. J. Obstet. Gynecol. 171, 1335-41, 1994.
168. Ulich, T R., Fann, M. J., Patterson, P. H., Williams, J. H., Samal, B., Del Castillo, J., Yin, S., Guo, K., and Remick, D. G. Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am. J. Physiol. 267, L442-6, 1994.
169. Block, M. I., Berg, M., McNamara, M. J., Norton, J. A., Fraker, D. L., and Alexander, H. R. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 178, 1085-90, 1993.
170. Ray, D. W., Ren, S., and Melmed, S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J. Clin. Invest. 97, 1852-9, 1996.
171. Villiger, P. M., Terkeltaub, R., and Lotz, M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J. Clin. Invest. 90, 488-96, 1992.
172. Musso, T., Badolato, R., Longo, D. L., Gusella, G. L., and Varesio, L. Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma. Blood 86, 1961-7, 1995.
173. Jorens, P. G., de Jongh, R., Bossaert, L. L., de Backer, W., Herman, A. G., Pollet, H., Bosmans, E., Taupin, J. L., and Moreau, J. F. High levels of LIF in ARDS. Cytokine 8, 873-876, 1996.
174. Taupin, J. L., Morel, D., Moreau, J. F., Gualde, N., Potaux, L., and Bezian, J. H. HILDA/LIF urinary excretion during acute kidney rejection. Transplantation 53, 655-58, 1992.
175. Blancho, G., Moreau, J. F., Anegon, I., and Soulillou, J. P. HILDA/LIF is present in the urine of rejecting kidney graft recipients. Transpl. Int. 5, 57-8, 1992.
176. Blancho, G., Moreau, J. F., Chabannes, D., Chatenoud, L., and Soulillou, J. P. HILDA/LIF, G.CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts. Transplantation 56, 597-602, 1993.
177. Blancho, G., Moreau, J. F., Chabannes, D., Chatenoud, L., and Soulillou, J. P. Human interleukin DA-1a HILDA/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes. Transplant. Proc. 25, 891-2, 1993.
178. Morel, D., Taupin, J. L., Combe, C., Potaux, L., Gualde, N., and Moreau, J. F. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients. Transplantation 58, 1190-5, 1994.
179. Verfaillie, C., and McGlave, P. LIF/HILDA: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood 77, 263-70, 1991.
180. Leary, A. G., Zeng, H. Q., Clark, S. C., and Ogawa, M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 89, 4013-7, 1992.
181. Verfaillie, C. M. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82, 2045-53, 1993.
182. Yamaguchi, M., Miki, N., Ono, M., Ohtsuka, C., Demura, H., Kurachi, H., Inoue, M., Endo, H., Taga, T., Kishimoto, T., and Miyake, A. Inhibition of growth hormone-releasing factor production in mouse placenta by cytokines using gp130 as a signal transducer. Endocrinology 136, 1072-8, 1995.
183. Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., Kontgen, F., and Abbondanzo, S. J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359, 76-9, 1992.
184. Schaafsma, M. R., Falkenburg, J. H., Duinkerken, N., Moreau, J. F., Soulillou, J. P., Willemze, R., and Fibbe, W. E. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures. Exp. Hematol. 20, 6-10, 1992.
185. Firkin, F. C., Birner, R., and Farag, S. Differential action of diffusible molecules in long-term marrow culture on proliferation of leukaemic and normal haemopoietic cells. Br. J. Haematol. 84, 8-15, 1993.
186. + cells. Blood 82, 84-95, 1993.
187. Gabutti, V., Timeus, F., Ramenghi, U., Crescenzio, N., Marranca, D., Miniero, R., Cornaglia, G., and Bagnara, G. P. Expansion of cord blood progenitors and use for hemopoietic reconstitution. Stem cells 11 Suppl., 105-12, 1993.
188. Szilvassy, S. J. and Cory, S. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood 84, 74-83, 1994.
189. Szilvassy, S. J., Weller, K. P., Lin, W., Sharma, A. K., Ho, A. S., Tsukamoto, A., Hoffman, R., Leiby, K. R., and Gearing, D. P. Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Blood 87, 4618-28, 1996.
190. Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., Cheng, L., Donovan, P. J., Peschon, J. J., Bartlett, P. F., Willis, C. R., Wright, B. D., Carpenter, M. K., Davison, B. L., and Gearing, D. P. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121, 1286-99, 1995.
191. Li, M., Sendtner, M., and Smith, A. Essential function of LIF receptor in motor neurons. Nature 378, 724-27, 1995.
192. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W. Z., Mori, C., Shiota, K., Yoshida, N., and Kishimoto, T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407-11, 1996.
193. Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., Darbonne, W. C., Knutzon, D. S., Yen, R., Chien, K. R., Baker, J. B., and Wood, W. I. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 92, 1142-6, 1995.
194. Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., and Wood, W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270, 10915-22, 1995
195. Sheng, Z., Pennica, D, Wood, W. I., and Chien, K. R. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122, 419-28, 1996.
196. Wollert, K. C., Taga, T., Saito, M., Narazaki, M., Kishimoto, T., Glembotski, C. C., Vernallis, A. B., Heath, J. K., Pennica, D., Wood, W. I., and Chien, K. R. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem. 271, 9535-45, 1996.
197. Ryffel, B. Pathology induced by leukemia inhibitory factor. Int. Rev. Exp. Pathol. 34, 69-72, 1993.
198. Villiger, P. M., Geng, Y., and Lotz, M. Induction of cytokine expression by leukemia inhibitory factor. J. Clin. Invest. 91, 1575-81, 1993.
199. Waring, P., Wall, D., Dauer, R., Parkin, D., and Metcalf, D. The effects of leukaemia inhibitory factor on platelet function. Brit. J. Haematol. 83, 80-87, 1993.
200. Farese, A. M., Myers, L. A., and MacVittie, T. J. Therapeutic efficacy of recombinant human leukemia inhibitory factor in primate model of radiation - induced marrow aplasia. Blood 84, 3675-8, 1994.
201. Block, M. I., Fraker, D. L., Strassmann, G., Billingsley, K. G., Arnold, W. S., Perus, C., and Alexander, H. R. Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor. Int. J. Cancer. 63, 245-9, 1995.
202. Lal, R. B., Rudolph, D., Buckner, C., Pardi, D., and Hooper, W. C. Infection with human T-lymphotropic viruses leads to constitutive expression of LIF anf IL6. Blood 81, 1827-32, 1993.
203. Broor, S., Kusari, A. B., Zhang, B., Seth, P., Richman, D. D., Carson, D. A., Wachsman, W., and Lotz, M. Stimulation of HIV replication in mononuclear phagocytes by leukemia inhibitory factor. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 7, 647-54, 1994
204. Moran, C. S., Campbell, J. H., Simmons, D. L., and Campbell, G. R. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis. Arterioscler. Thromb. 14, 1356-63, 1994.
205. Marusic, A., Kalinowski, J. F., Jastrzebski, S., and Lorenzo, J. A. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J. Bone. Miner. Res. 8, 617-24, 1993.
206. Kirby, M. L., Kumiski, D. H., Myers, T., Cerjan, C., and Mishima, N. Back-transplantation of chick cardiac neural crest cells cultured in LIF rescues heart development. Dev. Dyn. 198, 296-311, 1993.
207. Barnard, W., Bower, J., Brown, M. A., Murphy, M., and Austin, L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: Injured muscle expresses LIF mRNA. J. Neurol. Sci. 123, 108-113, 1994.
208. Papaxanthos-Roche, A., Taupin, J. L., Mayer, G., Daniel, J. Y., and Moreau, J. F. Human interleukin for DA cells or leukemia inhibitory factor is released by Vero cells in human embryo coculture. Fertil. Steril. 62, 648-50, 1994.
209. Sawai, K., Matsuzaki, N., Kameda, T., Hashimoto, K., Okada, T., Shimoya, K., Nobunaga, T., Taga, T., Kishimoto, T., and Saji, F. Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. J. Clin. Endocrinol. Metab. 80, 1449-56, 1995.
210. Leary, A. G., Wong, G. G., Clark, S. C., Smith, A. G., and Ogawa, M. LIF/ DIA/HILDA augments proliferation of human hematopoietic stem cells. Blood 75, 1960-64, 1990.
211. Fletcher, F. A., Williams, D. E., Maliszewski, C., Anderson, D., Rives, M., and Belmont, J. W. Murine LIF enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood 76, 1098-1103, 1990.
212. Fletcher, F. A., Moore, K. A., Ashkenazi, M., de Vries, P., Overbeek, P. A., Williams, D. E., and Belmont, J. W. LIF improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J. Exp. Med. 174, 837-845, 1991.
213. Moore, K. A., Deisseroth, A. B., Reading, C. L., Williams, D. E., and Belmont, J. W. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79, 1393-99, 1992.
214. Burstein, S. A., Mei, R. L., Henthorn, J., Friese, P., and Turner, K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J. cell. Physiology. 153, 305-12, 1992.
215. Gimble, J. M., Wanker, F., Wang, C. S., Bass, H., Wu, X., Kelly, K., Yancopoulos, G. D., and Hill, M. R. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein J. cell. Biochem. 54, 122-33, 1994.